GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo

Published:2015-04 Issue: Volume: Page:753
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Liang Chaozhao,Zhou Fayou,Chen Xianguo,Fan Song,Tai Sheng,Jiang Changqin,Zhang Yifei,Hao Zongyao,Zhou Jun,Shi Haoqiang,Zhang Li

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Therapy Resistance to Targeted Therapies in Prostate Cancer;Frontiers in Oncology;2022-05-24

2. The emerging role of cross-resistance between taxanes and AR-targeting therapy in metastatic prostate cancer;Journal of Clinical Urology;2022-04-12

3. Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells;Journal of Cellular and Molecular Medicine;2021-07-28

4. Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform;The Prostate;2021-03-18

5. Endocrinology of the Aging Prostate: Current Concepts;Frontiers in Endocrinology;2021-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP